AnaptysBio, Inc.

ANAB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$123,080$35,965$71,308$495,729
Short-Term Investments$262,293$354,939$369,933$52,368
Receivables$40,765$6,851$1,419$876
Inventory$0$0$0$0
Other Curr. Assets$5,738$9,080$4,545$4,903
Total Curr. Assets$431,876$406,835$447,205$553,876
Property Plant & Equip (Net)$16,232$18,272$19,987$21,841
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$35,470$27,026$142,935$67,097
Tax Assets$0$0$0$0
Other NC Assets$256$256$256$256
Total NC Assets$51,958$45,554$163,178$89,194
Other Assets$0$0$0$0
Total Assets$483,834$452,389$610,383$643,070
Liabilities
Payables$4,002$4,698$2,784$1,741
Short-Term Debt$1,925$1,777$1,637$1,505
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$39,501$30,967$21,633$12,853
Total Curr. Liab.$45,428$37,442$26,054$16,099
LT Debt$367,538$16,037$17,813$19,450
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$310,807$304,413$251,093
Total NC Liab.$367,538$326,844$322,226$270,543
Other Liabilities$0$0$0$0
Cap. Leases$16,037$17,814$19,450$20,955
Total Liabilities$412,966$364,286$348,280$286,642
Equity
Pref Stock$0$0$0$0
Common Stock$30$27$29$28
Retained Earnings-$759,327-$614,096-$450,477-$321,753
AOCI$305-$797-$5,246-$422
Other Equity$829,860$702,969$717,797$678,575
Total Equity$70,868$88,103$262,103$356,428
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$483,834$452,389$610,383$643,070
Net Debt$246,383-$18,151-$51,858-$474,774